Image For Activity Cover
Promises and Perils of Consumer Mobile Technologies in Cardiovascular Care: JACC Scientific Statement (JACC February 2024-1)
Direct-to-consumer (D2C) wearables are becoming increasingly popular in cardiovascular health management due to their affordability and capability to capture diverse health data. Wearables may enable continuous healthcare provider-patient partnerships and reduce the volume of episodic clinic-based care (thereby reducing healthcare costs). However, challenges arise from their unregulated use, including questionable data reliability, potential misinterpretation of information, unintended psychological impacts and an influx of clinically non-actionable data that may overburden the healthcare system. Further, these technologies could exacerbate, rather than mitigate, health disparities. Experience with wearables in Atrial Fibrillation (AF) underscores these challenges. The prevalent use of D2C wearables necessitates a collaborative approach among stakeholders to ensure effective integration into cardiovascular care. Wearables are heralding innovative disease screening, diagnosis, and management paradigms, expanding therapeutic avenues and anchoring personalized medicine. 

Valentin Fuster, MD, PhD, MACC

CME Editor
Ragavendra R. Baliga, MD

Mahmoud Houmsse, MD, FACC

Important Dates
Date of Release: January 29, 2024

Term of Approval/Date of CME/MOC Expiration: January 28, 2025
Availability: On-Demand
Expires on Jan 28, 2025
Cost: FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
Android App Download IOS App Download Powered By